Vudalimab Human Monoclonal Antibody
Vudalimabis a research-grade recombinant antibody targeting CD1. Produced in mammalian cells with native-like glycosylation. Highlights Research Grade: For PK/PD studies, assay development, and ADA research. Native Glycosylation: Mammalian expression ensures native-like patterns.
Product Specifications
Product Name Alternative
Programmed cell death protein 1, Protein PD-1, hPD-1, PD1, PDCD1, CD279, CD152, Cytotoxic T-lymphocyte protein 4, CTLA-4, CTLA4, Cytotoxic T-lymphocyte-associated antigen 4
UniProt
Q15116, P16410
Reactivity
Human
Clonality
Monoclonal
Conjugation
Unconjugated
Purification
Protein A/G purified from cell culture supernatant.
Concentration
Lot dependent
Purity
>95% purity as determined by SDS-PAGE.
Form
Liquid
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Tested Applications
ELISA, FA, FACS, In vivo
Host or Source
Human Humanized
Preservative
0.01M PBS, pH 7.4.
Isotype
Half-IGG1-kappa/ (scFv-kappa-heavy) -h-CH2-CH3
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
G2035-08K2-FITC 100 µL
GITR (Glucocorticoid Induced Tumor Necrosis Factor Receptor, Glucocorticoid-induced TNFR-related Protein, Activation-inducible TNFR Family Receptor, AITR, Tumor Necrosis Factor Receptor Superfamily Member 18, TNFRSF18) (FITC) discontinued
Sign In for Pricing
View Details 